Data is not available at this time.
Huafon Chemical operates as a specialized chemical producer focused primarily on spandex manufacturing, a polyurethane elastic fiber essential for textile applications. The company's core revenue model derives from producing and selling its flagship Qianxi spandex yarn, which serves diverse end-markets including intimate apparel, sportswear, medical bandages, and hygiene products. As a vertically integrated player, Huafon also engages in upstream chemical production of cyclohexanone and benzene derivatives, while managing complementary operations in power and heat cogeneration. Within China's competitive specialty chemicals sector, the company has established itself as a significant domestic spandex supplier, leveraging its integrated production capabilities to maintain cost efficiency. Its market position is strengthened by diverse application segments that provide some insulation against cyclical demand fluctuations in specific textile categories. The 2021 rebranding from Zhejiang Huafeng Spandex reflects strategic expansion beyond pure spandex production into broader chemical intermediates, signaling ambitions for diversified growth within the basic materials value chain.
Huafon Chemical generated CNY 26.9 billion in revenue for FY2024, achieving net income of CNY 2.22 billion with a net margin of approximately 8.2%. The company demonstrated solid cash generation with operating cash flow of CNY 3.02 billion, significantly exceeding capital expenditures of CNY 1.29 billion. This indicates efficient conversion of earnings into operating cash, supporting ongoing investments while maintaining financial flexibility. The diluted EPS of CNY 0.45 reflects reasonable profitability given the capital-intensive nature of chemical manufacturing.
The company exhibits moderate earnings power with operating cash flow covering capital expenditures by a factor of 2.3x, suggesting sustainable reinvestment capacity. While specific return metrics aren't provided, the relationship between operating cash flow and market capitalization implies a cash flow yield in the mid-single digits. The capital expenditure intensity relative to operating cash flow indicates a business requiring continuous investment to maintain competitive positioning in chemical production.
Huafon maintains a conservative financial structure with CNY 7.07 billion in cash against total debt of CNY 2.80 billion, resulting in a net cash position. This strong liquidity profile provides significant buffer against industry cyclicality. The cash-to-debt ratio of approximately 2.5x indicates robust financial health, with ample capacity to weather demand fluctuations or pursue strategic investments without compromising balance sheet stability.
The company maintains a shareholder-friendly approach with a dividend per share of CNY 0.15, representing a payout ratio of approximately 33% based on diluted EPS. This balanced capital allocation strategy supports both shareholder returns and reinvestment needs. The market capitalization of CNY 42.8 billion suggests investor expectations for stable performance, though specific growth rates would require historical comparison for trend analysis.
Trading at a market capitalization of CNY 42.8 billion, Huafon Chemical carries a P/E ratio of approximately 19.3x based on FY2024 earnings. The beta of 1.025 indicates stock volatility roughly in line with the broader market. This valuation multiple reflects market expectations for steady performance in the specialty chemicals sector, balancing growth prospects against cyclical industry dynamics.
Huafon's integrated production model and diversification into chemical intermediates provide structural advantages in cost management and supply chain stability. The company's net cash position offers strategic flexibility for capacity expansion or market consolidation opportunities. However, the outlook remains subject to raw material price volatility and textile demand cycles, requiring careful navigation of industry dynamics to maintain competitive positioning in China's evolving chemical landscape.
Company financial statementsShenzhen Stock Exchange disclosures
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |